Merck (MRK) Tops Q4 EPS by 1c
Merck (NYSE: MRK) reported Q4 EPS of $0.87, $0.01 better than the analyst estimate of $0.86. Revenue for the quarter came in at $10.48 billion versus the consensus estimate of $10.61 billion.
Merck sees FY2015 EPS of $3.32-$3.47, versus the consensus of $3.49.
For earnings history and earnings-related data on Merck (MRK) click here.